ClariVest Asset Management’s Sangamo Therapeutics SGMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-50,202
| Closed | -$377K | – | 778 |
|
|
2021
Q4 | $377K | Sell |
50,202
-2,991
| -6% | -$22.5K | 0.01% | 454 |
|
|
2021
Q3 | $479K | Sell |
53,193
-2,252
| -4% | -$20.3K | 0.02% | 443 |
|
|
2021
Q2 | $663K | Buy |
55,445
+124
| +0.2% | +$1.48K | 0.02% | 388 |
|
|
2021
Q1 | $693K | Sell |
55,321
-3,300
| -6% | -$41.3K | 0.02% | 352 |
|
|
2020
Q4 | $915K | Sell |
58,621
-80,061
| -58% | -$1.25M | 0.03% | 284 |
|
|
2020
Q3 | $1.31M | Sell |
138,682
-6,224
| -4% | -$58.8K | 0.04% | 275 |
|
|
2020
Q2 | $1.3M | Sell |
144,906
-3,596
| -2% | -$32.2K | 0.04% | 287 |
|
|
2020
Q1 | $946K | Buy |
148,502
+323
| +0.2% | +$2.06K | 0.03% | 306 |
|
|
2019
Q4 | $1.24M | Sell |
148,179
-99,897
| -40% | -$836K | 0.03% | 324 |
|
|
2019
Q3 | $2.25M | Sell |
248,076
-3,100
| -1% | -$28.1K | 0.05% | 246 |
|
|
2019
Q2 | $2.71M | Buy |
251,176
+140,450
| +127% | +$1.51M | 0.06% | 220 |
|
|
2019
Q1 | $1.06M | Sell |
110,726
-8,108
| -7% | -$77.4K | 0.02% | 392 |
|
|
2018
Q4 | $1.36M | Buy |
118,834
+2,586
| +2% | +$29.7K | 0.03% | 356 |
|
|
2018
Q3 | $1.97M | Sell |
116,248
-2,051
| -2% | -$34.8K | 0.03% | 326 |
|
|
2018
Q2 | $1.68M | Sell |
118,299
-9,722
| -8% | -$138K | 0.03% | 367 |
|
|
2018
Q1 | $2.43M | Buy |
128,021
+500
| +0.4% | +$9.5K | 0.04% | 313 |
|
|
2017
Q4 | $2.09M | Buy |
+127,521
| New | +$2.09M | 0.04% | 337 |
|